title: Inflammatory IL-1β-driven JNK activation in stage III melanoma.
authors.affiliation: Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
authors.forename: Yong
authors.initials: Y
authors.lastname: Qin
authors.forename: Denái R
authors.initials: DR
authors.lastname: Milton
authors.forename: Junna
authors.initials: J
authors.lastname: Oba
authors.forename: Zhen
authors.initials: Z
authors.lastname: Ding
authors.forename: Gregory
authors.initials: G
authors.lastname: Lizée
authors.forename: Suhendan
authors.initials: S
authors.lastname: Ekmekcioglu
authors.forename: Elizabeth A
authors.initials: EA
authors.lastname: Grimm
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D018572:Disease-Free Survival; D004789:Enzyme Activation; D005260:Female; D006801:Humans; D007249:Inflammation / Q000473:pathology*; D053583:Interleukin-1beta / Q000378:metabolism*; D048031:JNK Mitogen-Activated Protein Kinases / Q000378:metabolism*; D008297:Male; D008545:Melanoma / Q000201:enzymology* / Q000473:pathology*; D008875:Middle Aged; D009367:Neoplasm Staging; D010766:Phosphorylation; D016016:Proportional Hazards Models; D012878:Skin Neoplasms / Q000201:enzymology* / Q000473:pathology*
chemical_list: D053583:Interleukin-1beta; D048031:JNK Mitogen-Activated Protein Kinases